BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32849563)

  • 1. Properdin Pattern Recognition on Proximal Tubular Cells Is Heparan Sulfate/Syndecan-1 but Not C3b Dependent and Can Be Blocked by Tick Protein Salp20.
    Lammerts RGM; Talsma DT; Dam WA; Daha MR; Seelen MAJ; Berger SP; van den Born J
    Front Immunol; 2020; 11():1643. PubMed ID: 32849563
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal disease.
    Zaferani A; Vivès RR; van der Pol P; Hakvoort JJ; Navis GJ; van Goor H; Daha MR; Lortat-Jacob H; Seelen MA; van den Born J
    J Biol Chem; 2011 Feb; 286(7):5359-67. PubMed ID: 21135110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor h and properdin recognize different epitopes on renal tubular epithelial heparan sulfate.
    Zaferani A; Vivès RR; van der Pol P; Navis GJ; Daha MR; van Kooten C; Lortat-Jacob H; Seelen MA; van den Born J
    J Biol Chem; 2012 Sep; 287(37):31471-81. PubMed ID: 22815489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properdin binding to complement activating surfaces depends on initial C3b deposition.
    Harboe M; Johnson C; Nymo S; Ekholt K; Schjalm C; Lindstad JK; Pharo A; Hellerud BC; Nilsson Ekdahl K; Mollnes TE; Nilsson PH
    Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E534-E539. PubMed ID: 28069958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mechanism of complement inhibition unmasked by a tick salivary protein that binds to properdin.
    Tyson KR; Elkins C; de Silva AM
    J Immunol; 2008 Mar; 180(6):3964-8. PubMed ID: 18322205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monomeric C-reactive protein inhibits renal cell-directed complement activation mediated by properdin.
    O'Flynn J; van der Pol P; Dixon KO; Prohászka Z; Daha MR; van Kooten C
    Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1308-16. PubMed ID: 26984957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the function of activated properdin by squid chondroitin sulfate E glycosaminoglycan and murine bone marrow-derived mast cell chondroitin sulfate E proteoglycan.
    Wilson JG; Fearon DT; Stevens RL; Seno N; Austen KF
    J Immunol; 1984 Jun; 132(6):3058-63. PubMed ID: 6427331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation by tubular cells is mediated by properdin binding.
    Gaarkeuken H; Siezenga MA; Zuidwijk K; van Kooten C; Rabelink TJ; Daha MR; Berger SP
    Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1397-403. PubMed ID: 18753294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-complement activity of the Ixodes scapularis salivary protein Salp20.
    Hourcade DE; Akk AM; Mitchell LM; Zhou HF; Hauhart R; Pham CT
    Mol Immunol; 2016 Jan; 69():62-9. PubMed ID: 26675068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crotamine/siRNA Nanocomplexes for Functional Downregulation of Syndecan-1 in Renal Proximal Tubular Epithelial Cells.
    Campeiro JD; Dam WA; Hayashi MAF; van den Born J
    Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and functional characterization of Salp20, an Ixodes scapularis tick salivary protein that inhibits the complement pathway.
    Tyson K; Elkins C; Patterson H; Fikrig E; de Silva A
    Insect Mol Biol; 2007 Aug; 16(4):469-79. PubMed ID: 17651236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properdin has an ascendancy over factor H regulation in complement-mediated renal tubular damage.
    Nagamachi S; Ohsawa I; Suzuki H; Sato N; Inoshita H; Hisada A; Honda D; Shimamoto M; Shimizu Y; Horikoshi S; Tomino Y
    BMC Nephrol; 2014 May; 15():82. PubMed ID: 24885016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides.
    Talsma DT; Poppelaars F; Dam W; Meter-Arkema AH; Vivès RR; Gál P; Boons GJ; Chopra P; Naggi A; Seelen MA; Berger SP; Daha MR; Stegeman CA; van den Born J;
    Front Immunol; 2020; 11():732. PubMed ID: 32425936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
    Farries TC; Lachmann PJ; Harrison RA
    Biochem J; 1988 May; 252(1):47-54. PubMed ID: 3421908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies.
    Loeven MA; Maciej-Hulme ML; Yanginlar C; Hubers MC; Kellenbach E; de Graaf M; van Kuppevelt TH; Wetzels J; Rabelink TJ; Smith RJH; van der Vlag J
    Front Immunol; 2021; 12():676662. PubMed ID: 34489931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
    J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of C3b(2)--IgG complexes with complement proteins properdin, factor B and factor H: implications for amplification.
    Jelezarova E; Vogt A; Lutz HU
    Biochem J; 2000 Jul; 349(Pt 1):217-23. PubMed ID: 10861231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
    Sahu A; Kay BK; Lambris JD
    J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of heparanase by albumin and advanced glycation end products in proximal tubular cells.
    Masola V; Gambaro G; Tibaldi E; Onisto M; Abaterusso C; Lupo A
    Biochim Biophys Acta; 2011 Aug; 1813(8):1475-82. PubMed ID: 21600934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Properdin in Killing of Non-Pathogenic
    Martinez APG; Abreu PAE; de Arruda Vasconcellos S; Ho PL; Ferreira VP; Saggu G; Barbosa AS; Isaac L
    Front Immunol; 2020; 11():572562. PubMed ID: 33240263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.